Where Will BioNTech Be in 3 Years?

Where Will BioNTech Be in 3 Years?
·4 min read

As half of the duo behind one of the world's most widely used and effective COVID-19 vaccines, BioNTech (NASDAQ: BNTX) is well on its way to enduring stardom in the healthcare sector. Far from content to keep playing second fiddle to collaborator Pfizer (NYSE: PFE), the biotech looks to be on a path toward ever-greater independence.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting